Gene · 171389
Papers1,410
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,410
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ER Stress Regulates HIV Tat and Alcohol-Induced NLRP6 Activation in Astrocytes. | CNS Neurosci Ther | 2026 | 42806587 | PubTator, text mining | PubMed |
| Structural mechanisms for ATP-mediated inhibition of human NLRP6 inflammasome. | Nat Struct Mol Biol | 2026 | 42711541 | PubTator, text mining | PubMed |
| Expression, Regulation and Therapeutic Implications of Nod-Like Receptors in Endodontics: A Narrative Review. | Int Endod J | 2026 | 42677679 | PubTator, text mining | PubMed |
| NLRP6 as a candidate segmental barrier to carcinogenesis in the human gut: a hypothesis. | Front Immunol | 2026 | 42620674 | PubTator, text mining | PubMed |
| GSDMB as a Therapeutic and Prognostic Target in Clear Cell Renal Cell Carcinoma: Insights From Pyroptosis-Related Gene Analysis. | Front Biosci (Landmark Ed) | 2026 | 42530271 | PubTator, text mining | PubMed |
| Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway". | Haematologica | 2026 | 42489079 | PubTator, text mining | PubMed |
| Inflammasomes in Intestinal Inflammation: Guardians of Mucosal Homeostasis, Amplifiers of Disease, and Targets for Intervention. | Intern Med | 2026 | 42402409 | PubTator, text mining | PubMed |
| Urolithin A activates aryl hydrocarbon receptor-NLRP6-mediated pathways in intestinal epithelial cells to modulate mucosal immunity and strengthen gut barrier integrity. | Nat Commun | 2026 | 42336837 | PubTator, text mining | PubMed |
| Supramolecular Assemblies Drive Activation of Inflammasomes. | Adv Exp Med Biol | 2026 | 42334537 | PubTator, text mining | PubMed |
| NLR inflammasome pathways: key targets for pathogenesis and therapy of metabolic diseases. | Front Immunol | 2026 | 42292355 | PubTator, text mining | PubMed |
| Multivirulent Plasmopara viticola strains from Cilaos on Réunion Island break down Rpv1, Rpv3.1 and Rpv10 mediated resistance of grapevine. | BMC Plant Biol | 2026 | 42219456 | PubTator, text mining | PubMed |
| NLR Inflammasomes in Viral Infections: From Molecular Mechanisms to Therapeutic Interventions. | Viruses | 2026 | 42198749 | PubTator, text mining | PubMed |
Redefining the Evolution of Pulpal Pathology: Inflammasomes as Central Integrative Hubs and Biological Switches Governing the Transition From Reversible to Irreversible Pulpal Inflammation Beyond Symptom-Based Classification. | Int Endod J | 2026 | 42186678 | PubTator, text mining | PubMed |
| Ciclopirox Olamine Inhibits the NLRP3 Inflammasome to Alleviate Inflammatory Diseases. | Adv Sci (Weinh) | 2026 | 42154002 | PubTator, text mining | PubMed |
| Multi-Omics Mendelian Randomization and Clinical Validation Implicate NLRP6 as a Candidate Autophagy-Related Gene in Systemic Lupus Erythematosus. | Genes (Basel) | 2026 | 42074584 | PubTator, text mining | PubMed |
| Liquid-Liquid Phase Separation in Viral Infection and Immunology. | MedComm (2020) | 2026 | 41930348 | PubTator, text mining | PubMed |
| Human NLRP3 inflammasome activation leads to formation of condensate at the microtubule organizing center. | Sci Adv | 2026 | 41894512 | PubTator, text mining | PubMed |
| Application and mechanistic research of novel therapeutic strategies in cisplatin-resistant small cell lung cancer. | Ann Med | 2026 | 41869709 | PubTator, text mining | PubMed |
| Subcellular calcium dynamics and organelle perturbations in resistosome-mediated cell death. | Proc Natl Acad Sci U S A | 2026 | 41849389 | PubTator, text mining | PubMed |
| Colorectal cancer pathogenesis, oncogenic signaling networks and targeted therapeutic advances. | Mol Biomed | 2026 | 41826571 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/171389/papers